Back to search results
NCT06743282

Senyo Health With Substance Use Disorder (SUD) in Primary Care

Enrolling by Invitation
NAAges 18+InterventionalTreatment
Mayo Clinic
~60 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Senyo AppFollow-up

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Brief Substance Craving Scale (BSCS)
Measured over Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months
+1 more outcome measured

Conditions

Substance Use Disorders
Substance Abuse

Explore related trials

Substance use disorder

Where it's being run

2 sites across 2 states
Arizona1
Minnesota1

Study leadership

  • Tyler Oesterle · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to read, write, and understand English
Minimum DAST (1+), audit-C score (3+)
Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care.
Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site;
Eligibility determined by ASAM Assessment

Exclusion

Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis
Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment
Needing a higher level of mental health care as demonstrated by ASAM32 assessment.
Decline to answer suicidality questions.
Already admitted into or about to initiate treatment in another addiction treatment program.

What this trial measures

  • Brief Substance Craving Scale (BSCS)Baseline, weekly for 12 weeks, 4 months, 5 months, 6 months

    The Brief Substance Craving Scale is a 16 item, self-report instrument that assesses craving for substances of abuse over a 24 hour period. Intensity and frequency of craving are recorded on a five-point Likert scale, with 0 = Not at all, 1 = Slight, 2 = Moderate, 3 = Considerable, and 4 = Extreme.

  • Timeline Follow BackBaseline, weekly for 12 weeks, 4 months, 5 months, 6 months

    Timeline Follow Back is an assessment to document substance use over a specific period of time